To explore this issue further, we repeated the experiment using a different ER ligand, 4-hydroxytamoxifen (4HT). In the absence of competitor, 4HT had little effect on the association of endogenous Gal4 with its cognate promoter (Fig. 1a, red line) . Consistent with the different effects of these two ligands on basal association of Gal4 with chromatin, the two compounds gave very different results in the presence of competitor (Fig. 1b) . As Nalley et al. published 3 , the addition of b-oestradiol to yeast expressing the competitor protein resulted in little if any reduction in the levels of endogenous Gal4 at the GAL1/10 promoter, creating the impression that most promoter-bound Gal4 resisted competition (Fig. 1b, blue line) . In the presence of 4HT, however, the opposite result was obtained, and ,75% of endogenous Gal4 was competed from the chromatin within 15 min of the ligand addition (Fig. 1b, red line) . Notably, the loss of Gal4-chromatin association was accompanied by loading of the competitor onto the GAL1/10 promoter (Fig. 1c) , consistent with the notion that the 4HT-activated competitor can displace endogenous Gal4 from the promoter. Although the competitor protein associated with the GAL1/10 promoter with apparently slower kinetics than endogenous Gal4 dissociated (compare red line in Fig. 1b with pink line in Fig. 1c) , it is worth noting that endogenous Gal4 can bind cooperatively to several sites in vivo 7 . There are four Gal4-binding sites in the GAL1/10 promoter. Thus, a single competitor bound to one of the sites could have the effect of destabilizing multiple Gal4-promoter complexes, leading to efficient displacement of endogenous Gal4 at substoichiometric levels of competitor.
On the basis of our observations, we propose that the recalcitrance of Gal4-promoter complexes originally reported by Nalley et al. 3 is an artefact of using b-oestradiol to stimulate the competitor. Activating the competitor with 4HT (Fig. 1b) , or normalizing the b-oestradiol signal to the important 'no competitor' control (Fig. 1d) , shows that Gal4 can indeed be rapidly displaced from promoter DNA in vivo. Their conclusion that Gal4-promoter complexes lock in and have long half-lives under activating conditions is thus unsustainable. ChIP signal is normalized to that at time zero. b, As in a, except that experiment was performed in yeast expressing the Myc-G4-ER-VP16 competitor (supplied by T. Kodadek 3 ). c, As in the 4HT experiment in b, except that ChIP was used to monitor association of the Myc-G4-ER-VP16 competitor with the GAL1/10 promoter. The corresponding non-competitor controls are also shown. To calculate the percentage binding in this case, ChIP signals were normalized to those from a Myc-G4-ER-VP16 ChIP (60-min time point) performed in the absence of endogenous Gal4, which corresponds to the total amount of competitor that can bind in this assay. 
METHODS
Yeast (BY4741) with or without competitor (Myc-G4-ER-VP16) 3 were grown in complete synthetic medium (CSM) (2% raffinose) and Gal4 was induced by transferring yeast to media containing 2% galactose for 1 h. Yeast were then treated with 1 mM 17-b oestradiol (Sigma) or 100 mM 4-hydroxytamoxifen (Sigma) for the indicated times. ChIP was preformed 5 using either the Gal4-TA C-10 (anti-GAL4; Santa Cruz) or AB1 (anti-Myc; Calbiochem) antibodies. DNA enrichment was calculated as described 8 using ACT1 as the reference locus.
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